| ID | 1568 |
|---|
| No | 1568 |
|---|
| Brand Name | ATORZET 10/20 |
|---|
| Ingredients | ATORVASTATIN CALCIUM EQ.TO ATORVASTATIN 20 MG, EZETIMIBE 10 MG |
|---|
| Dosage Form | FILM COATED TABLET |
|---|
| Primary Packaging | ALU-ALU BLISTER |
|---|
| Storage | |
|---|
| Shelf Life | 3 YEARS |
|---|
| Pack Size | BOX OF 3 X 10'S |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | AS SUBSTITUTION THERAPY FOR TREATMENT OF ADULTS WITH PRIMARY (HETEROZYGOUS AND HOMOZYGOUS FAMILIAL AND NON-FAMILIAL) HYPERCHOLESTEROLAEMIA OR MIXED HYPERLIPIDAEMIA ALREADY CONTROLLED WITH ATORVASTATIN AND EZETIMIBE GIVEN CONCURRENTLY AT THE SAME DOSE LEVEL |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL | NULL |
|---|
| Description | ORANGE COLORED, ROUND SHAPED BICONVEX, FILM COATED TABLET, PLAIN ON BOTH SIDE |
|---|
| Note | |
|---|
| License Owner | LAO NIYOM PHARMA SOLE CO.,LTD |
|---|
| Manufacturer | MEDIWIN PHARMACEUTICALS |
|---|
| Country | INDIA |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 08 I 5595/23 |
|---|
| FDD Registration Date | 05/09/2023 |
|---|
| Expiry Date | 04/09/2026 |
|---|
